Review Article
The Role of Nutraceuticals in Chemoprevention and Chemotherapy and Their Clinical Outcomes
Table 5
Factors conducive to the anticarcinogenic efficacy of nutraceuticals.
| Factors | Possible effects on the bioactive components in the dietary supplement |
| Bioavailability | Metabolism | Time taken to achieve maximum plasma concentration | Maximum plasma concentration, half-life |
| Method of ingestion | Oral | Intraperitoneal | Subcutaneous |
| Form of ingestion | Powder/capsule | Liquid | Cooked (solid) | Raw (solid) |
| Formulation | Ratio of pure to the compound conjugates |
| Stability | Preference for an acidic or basic environment (pH) |
| Mechanism of action | Direct via receptors on the cell surface or into the nuclear region via channels | Indirect conjugated metabolites affecting parts of metabolic pathways |
|
|